JAMA · 1969 · 58 citations · 10 references
MedicineHematologyPharmacologyClinical BiochemistryHemostasisTransfusion MedicineCoagulation AbnormalitiesCoagulation Factor DeficienciesHemostasis DisordersHemostatic AgentsHemostatic DisordersThrombotic DisordersCoagulation Cascade DysregulationFactor Ix PhysiologyLiver Disease CoagulopathyProthrombin ActivationProthrombin Complex Concentrate UseThrombosis MechanismsTricalcium Phosphate
Chromatographic DEAE-adsorbed prothrombin complex (Hemoplex) was administered to 14 patients with disorders involving depression in the levels of factors II, VII, IX, and X. These included patients with Christmas disease, liver disease, and hypoprothrombinemia induced by bishydroxycoumarin (Dicumarol). In every instance, prompt hemostasis was achieved as evidenced by cessation of hemorrhage and correction of procoagulant deficits. A frequently seen immediate improvement in hemostasis was attributed to the presence of activated surface factor. Limited usage of tricalcium phosphate adsorbed prothrombin complex failed to show significant improvement in subsequent levels of circulating factor IX.
10
ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.
Oscar D. Ratnoff, J. D. Crum · PubMed · 1964 · 152 citations
Clinical Use of Human Prothrombin Complexes
James L. Tullis, M. Melin, Paul Jurigian · New England Journal of Medicine · 1965 · 65 citations
Medicine, Biochemistry, Hematology +12